Add to my selection
Print

RELENZA

Medicine - Posted on Jul 01 2020 - Updated on Jul 01 2020
Active substance (DCI)
  • zanamivir
history (3)
Technical information
ATC code
  • J05AH01
Manufacturer
GLAXOSMITHKLINE
Presentation

RELENZA 5 mg/dose, poudre pour inhalation en récipient unidose (code CIS : 62815549)
5 plaquette(s) thermoformée(s) aluminium PVC-aluminium polyamide (DISKHALER) de 4 dose(s) (CIP : 34009 351 974 8 1)

All our publications